Font Size: a A A

Effects Of Sacubitril/Valsartan On Cardiac Function And Nutritional Status In Elderly Patients With Heart Failure In Ischemic Cardiomyopathy

Posted on:2021-02-15Degree:MasterType:Thesis
Country:ChinaCandidate:J X YaoFull Text:PDF
GTID:2404330614464107Subject:Internal medicine
Abstract/Summary:PDF Full Text Request
Objective: The purpose of this study was to investigate the effects of sacubitril/valsartan on cardiac function and nutritional status in elderly patients with heart failure in ischemic cardiomyopathy.Methods: A total of 118 elderly patients with heart failure due to ischemic cardiomyopathy in Tangshan Gongren Hospital were randomly divided into enalapril group(ACEI group,n=61cases)and sacubitril/valsartan group(ARNI group,n=57cases).We analyze the changes in left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD),left ventricular mass index(LVMI),N-terminal pro-brain natriuretic peptide(NT-pro BNP),Kansas City cardiomyopathy questionnaire(KCCQ)score,albumin(ALB),prealbumin(PA)and the geriatric nutritional risk index(GNRI)score after 6 months of treatment in the two groups.Results:1.There were no significant differences in LVEF,LVEDD,LVESD,LVMI,NT-pro BNP,KCCQ score,ALB,PA and GNRI score between the two groups before treatment(P>0.05).2.After 6 months of treatment,in both of the two groups,LVEF,KCCQ score were increased,LVEDD,LVESD,LVMI and NT-pro BNP were decreased,and all the differences were statistically significant(P<0.05);furthermore,the LVEF,KCCQ score,LVEDD,LVESD,LVMI and NT-pro BNP of the ARNI group were significantly improved compared with the ACEI group(P<0.05).3.After 6 months of treatment,in the ARNI group,the ALB,PA and GNRI score were all increased with statistically significant differences(P<0.05);there were no significant differences in ALB,PA and GNRI among the ACEI group after treatment(P>0.05).4.After treatment,the probability of adverse reaction events in the two groups was not statistically significant(P>0.05).Conclusion: Sacubitril/valsartan can not only effectively improve the cardiac function and nutritional status of elderly patients with heart failure in ischemic cardiomyopathy,but also improve the quality of life and the prognosis.
Keywords/Search Tags:Sacubitril/valsartan, Ischemic cardiomyopathy, Heart failure, Cardiac function, Nutritional status
PDF Full Text Request
Related items